Table 2.
Various parameters of endogenous insulin secretory capacity in this study participants.
| Parameter | All subjects (n = 71) | Withdrawal group (n = 35) | Non-withdrawal group (n = 36) | p value |
|---|---|---|---|---|
| Fasting blood glucose (mg/dL) | 136.2 ± 35.7 | 134.1 ± 41.0 | 138.2 ± 29.5 | n.s |
| Fasting C-peptide (ng/mL) | 1.54 ± 0.80 | 1.63 ± 0.73 | 1.46 ± 0.87 | n.s |
| Fasting C-peptide index | 1.17 ± 0.61 | 1.27 ± 0.63 | 1.07 ± 0.58 | n.s |
| Blood glucose after glucagon loading (mg/dL) | 153.1 ± 35.5 | 150.0 ± 40.0 | 156.4 ± 30.2 | n.s |
| C-peptide after glucagon loading (ng/mL) | 2.73 ± 1.30 | 3.05 ± 1.14 | 2.41 ± 1.38 | <0.05 |
| C-peptide index after glucagon loading | 1.83 ± 0.91 | 2.11 ± 0.90 | 1.55 ± 0.83 | <0.05 |
| ΔCPR (ng/mL) | 1.19 ± 0.70 | 1.43 ± 0.67 | 0.95 ± 0.66 | <0.05 |
| HOMA-β (%) | 22.9 ± 16.2 | 25.7 ± 15.6 | 19.9 ± 16.3 | n.s |
| SUIT | 35.8 ± 23.5 | 39.0 ± 22.6 | 33.2 ± 24.1 | n.s |
| 24-hour urine C-peptide (μg/day) | 37.2 ± 23.1 | 36.8 ± 24.5 | 37.5 ± 21.7 | n.s |
Data presented as mean ± standard deviation. ΔCPR, delta C-peptide; HOMA-β, homeostatic model assessment beta cell function; SUIT, secretory unit of islet transplantation.
NS, Not Significant.